| 138-52-3 |
| Salicoside |
| D-(-)-Salicin |
| Salicyl alcohol glucoside |
| D(-)-Salicin |
| 2-(Hydroxymethyl)phenyl beta-D-glucopyranoside |
| Saligenin beta-D-glucopyranoside |
| 2-(Hydroxymethyl)phenyl-beta-d-glucopyranoside |
| Salicinum |
| o-(Hydroxymethyl)phenyl beta-D-glucopyranoside |
| CHEBI:17814 |
| DTXSID10883326 |
| NSC-5751 |
| (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol |
| 4649620TBZ |
| (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(2-(hydroxymethyl)phenoxy)oxane-3,4,5-triol |
| RefChem:884384 |
| DTXCID901022864 |
| Salicine |
| D-Salicin |
| (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)phenoxy)tetrahydro-2H-pyran-3,4,5-triol |
| MFCD00006590 |
| Saligenin-beta-D-glucopyranoside |
| C13H18O7 |
| alpha-Hydroxy-o-tolyl beta-D-glucopyranoside |
| Benzyl alcohol, o-hydroxy-, o-glucoside |
| AI3-19099 |
| SPECTRUM1502255 |
| B-D-Glucopyranoside, 2-(hydroxymethyl)phenyl |
| D-()-Salicin |
| SDCCGMLS-0066698.P001 |
| NCGC00142605-01 |
| NSC 5751 |
| (2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)-phenoxy)tetrahydro-2H-pyran-3,4,5-triol |
| (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]tetrahydropyran-3,4,5-triol |
| (2S,4S,5S,3R,6R)-6-(hydroxymethyl)-2-[2-(hydroxymethyl)phenoxy]-2H-3,4,5,6-tet rahydropyran-3,4,5-triol |
| SMR000112301 |
| Salicin [USP] |
| SR-05000001594 |
| Salicin (6CI,8CI) |
| EINECS 205-331-6 |
| delta-Salicin |
| UNII-4649620TBZ |
| 2-(Hydroxymethyl)phenyl hexopyranoside |
| SA0 |
| Salicin (Standard) |
| Spectrum_001230 |
| 2-(Hydroxymethyl)phenyl-.beta.-d-glucopyranoside |
| SALICIN [MI] |
| SALICINUM [HPUS] |
| 2-(Hydroxymethyl)phenyl b-D-glucopyranoside |
| Spectrum2_000756 |
| Spectrum3_000948 |
| Spectrum4_001058 |
| Spectrum5_000971 |
| D-()-Salicin;Salicoside |
| bmse000315 |
| D-SALICIN [USP-RS] |
| SCHEMBL24936 |
| KBioGR_001356 |
| KBioSS_001710 |
| Saligenin-b-D-glucopyranoside |
| MLS000563050 |
| MLS001306490 |
| DivK1c_000030 |
| S0625_SIGMA |
| SPBio_000772 |
| CHEMBL462997 |
| MEGxp0_000685 |
| orb1310611 |
| Salicin (Salicoside, Salicine) |
| SCHEMBL29891411 |
| ACon1_000373 |
| GTPL12454 |
| HMS500B12 |
| HY-N0149R |
| KBio1_000030 |
| KBio2_001710 |
| KBio2_004278 |
| KBio2_006846 |
| KBio3_002016 |
| NINDS_000030 |
| GLXC-13826 |
| HMS1921P08 |
| HMS2092F14 |
| HMS2268J11 |
| HMS3884B15 |
| Pharmakon1600-01502255 |
| HY-N0149 |
| MSK40324 |
| Saligenin beta-delta-glucopyranoside |
| Saligenin-beta-delta-glucopyranoside |
| D-(-)-Salicin, analytical standard |
| CCG-40332 |
| NSC758201 |
| s2351 |
| SBB012498 |
| ZINC03847505 |
| AKOS004907439 |
| AC-8042 |
| CS-8027 |
| D-(-)-Salicin, >=99% (GC) |
| MS01266 |
| NSC-758201 |
| IDI1_000030 |
| NCGC00142605-02 |
| NCGC00142605-04 |
| ST069327 |
| SY038043 |
| SALICYL ALCOHOL GLUCOSIDE [WHO-DD] |
| SBI-0051746.P002 |
| 2(hydroxymethyl)phenyl-beta-D-glucopyranoside |
| NS00015239 |
| S0003 |
| SW219123-1 |
| |A-D-Glucopyranoside, 2-(hydroxymethyl)phenyl |
| C01451 |
| 2-(Hydroxymethyl)-phenyl-beta-D-glucopyranoside |
| 2-(hydroxymethyl)phenyl-O-beta-D-glucopyranoside |
| AB00052296_07 |
| 138S523 |
| F212842 |
| Q419173 |
| SR-05000001594-1 |
| SR-05000001594-2 |
| BRD-K64614248-001-02-4 |
| BRD-K64614248-001-06-5 |
| BRD-K64614248-001-11-5 |
| BRD-K64614248-001-12-3 |
| EAD32BE1-198E-432C-9F44-DC0DC9A3305B |
| Salicin, European Pharmacopoeia (EP) Reference Standard |
| D-Salicin, United States Pharmacopeia (USP) Reference Standard |
| 2-(Hydroxymethyl)phenyl-beta-D-glucopyranoside, Salicoside, Salicyl alcohol glucoside, Saligenin beta-D-glucoside |
|
There are more than 10 synonyms. If you wish to see them all click here.
|